# Protalix BioTherapeutics, Inc.: Form 8-K, filed May 9, 2018

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2018-05-09
- Accepted by EDGAR: May 9, 2018, 07:08 ET
- Period: 2018-05-09
- Accession: 0001144204-18-026337
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000114420418026337/tv493429_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000114420418026337/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000114420418026337/tv493429_8k.htm

Filed May 9, 2018.
Source: SEC EDGAR, the filing index for accession 0001144204-18-026337. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
